Abstract
Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder characterised by epistaxis, telangiectases, and visceral arteriovenous malformations. Hyperdynamic blood flow associated with arteriovenous malformations may lead to pulmonary hypertension, global heart failure, and valvular insufficiencies. We report a patient who had HHT with severe heart failure (New York Heart Association [NYHA] class III-IV) and pulmonary hypertension caused by an hepatic arteriovenous fistula. After successful transarterial embolisation of the right branch of the hepatic artery with polyvinyl alcohol (PVA) particles and coils, 4 to 7 mm in size, the patient was discharged with functional class II (NYHA) heart failure.
[1] Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telengiectasia (Osler-Weber-Rendu disease). New insights in pathogenesis, complications, and treatment. Arch Intern Med 156:714–719, 1996 http://dx.doi.org/10.1001/archinte.156.7.71410.1001/archinte.156.7.714Search in Google Scholar
[2] Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936 http://dx.doi.org/10.1056/NEJM20000928343130510.1056/NEJM200009283431305Search in Google Scholar
[3] Shovlin CL, Guttmacher AE, Buscarini E, Faughan ME, Hyland RH, Westermann CJ, et al: Diagnostic cirteria for hereditary hemorrhagic telengectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–67 http://dx.doi.org/10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-PSearch in Google Scholar
[4] Bourgeois N, Delcour C, Deviere J, Francois A, Lambert M, Crener M. Osler-Weber-Rendu disease associated with hepatic involvement and high-output heart failure. J Clin Gastroenterol 1990;12:236–8 http://dx.doi.org/10.1097/00004836-199004000-0003010.1097/00004836-199004000-00030Search in Google Scholar
[5] Chavan A, Galanski M, Wagner S, et al. Hereditary hemorrhagic telangiectasia:effective protocol for embolization of hepatic vascular malformationsexperience in five patients. Radiology 1998;209:735–9 10.1148/radiology.209.3.9844667Search in Google Scholar
[6] Roman CF, Cha SD, Incarvito J, Cope C, Maranhao V. Transcatheter embolization of hepatic arteriovenous fistula in Osler-Weber-Rendu disease: a case report. Angiology 1987;38:484–8 http://dx.doi.org/10.1177/00033197870380061010.1177/000331978703800610Search in Google Scholar
[7] Göthlin JH, Nordgard K, Johnson K, Nyman U. Hepatic telangiectasia in Osler’s disease treated with arterial embolization. Report of 2 cases. Eur J Radiol 1982;2:27–30 Search in Google Scholar
[8] Allison DJ, Jordan H, Hennesy O. Therapeutic embolization of the hepatic artery. A review of 75 procedures. Lancet 1985;1:595–9 http://dx.doi.org/10.1016/S0140-6736(85)92142-710.1016/S0140-6736(85)92142-7Search in Google Scholar
[9] Whiting JH Jr, Morton KA, Datz FL, Patch GG, Miller FJ Jr. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: case report. J Nucl Med 1992;33:260–2 Search in Google Scholar
[10] Larson AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 2003;36:149–158 http://dx.doi.org/10.1097/00004836-200302000-0001310.1097/00004836-200302000-00013Search in Google Scholar
[11] Spurny OM, Pierce JA. Cardiac output in systemic arteriovenous fistula complicated by heart failure. Am Heart J 1961;61:21–4 http://dx.doi.org/10.1016/0002-8703(61)90512-910.1016/0002-8703(61)90512-9Search in Google Scholar
[12] Whiting JH, Morton KA, Datz FL, Patch GG, Miller FJ. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: Case report. J Nucl Med 1992;33:260–262 Search in Google Scholar
[13] Bonderman D, Nowotny R, Skoro-Sajer N, Adbrecht C, Lang IM. Bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia. Eur J Clin Invest 2006;36Suppl 3:71–2 10.1111/j.1365-2362.2006.01683.xSearch in Google Scholar
[14] Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A, 2008; 1;146A:2551–6 10.1002/ajmg.a.32468Search in Google Scholar PubMed
[15] Garcia-Tsao G, Korzenik JR, Young L et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931–6 http://dx.doi.org/10.1056/NEJM20000928343130510.1056/NEJM200009283431305Search in Google Scholar PubMed
© 2009 Versita Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
